comparemela.com

Latest Breaking News On - Elektromedizinische ger - Page 1 : comparemela.com

Showing Examiner Error In Advanced Bionics Framework Based On Arguments And Evidence Patent Owner Presented During Prosecution - Patent

In Samsung Bioepis Co, Ltd. v. Alexion Pharms., Inc., IPR2023-01070, Paper 9 (PTAB Dec. 19, 2023), the Patent Trial and Appeal Board ("the Board").

B braun melsungenAlexion pharmsAlexion pharms incSee advanced bionicsSamsung bioepis co ltdPatent trialAppeal boardPatent ownerAdvanced bionicsDisclosure statementsElektromedizinische gerBraun melsungenShowing examiner error in advanced bionics framework based on arguments and evidence patent owner presented during prosecutionIntellectual property

Petitioner Prevails In Institution Decision Do-Over After Director Steps In - Patent

On November 6, 2023, the PTAB issued an decision instituting inter partes review of U.S. Patent No. 10,681,009 B2 ("the '009 patent") in Keysight Technologies, Inc. v. Centripetal Networks, Inc., IPR2022-01421.

Kathi vidalNetworks incPacket networkTechnologies incKeysight technologies incCentripetal networks incKeysight technologiesAdvanced bionicsElektromedizinische gerPatent ownerCentripetal networksWritten decisionDirector vidalDirector reviewPatent owner preliminary responseInterim director review process

Limitations Absent From A Notice Of Allowability May Be Material - Patent

The Petition for institution concerns Patent No. 10,681,009 B2 ("the '009 patent"), directed towards "Rule Swapping in a Packet Network."

Kathi vidalCentripetal networksKeysight technologies incCisco systems incCentripetal networks incPrecedential opinion panelKeysight technologiesFinal written decisionPrecedential opinionDirector vidalDirector reviewElektromedizinische gerAdvanced bionicsAdvanced bionicCorrected noticeCisco systems

To Err Is Human, To Forgive Divine – If There Was Error - Patent

In Apotex, Inc. v. Auspex Pharms., Inc., IPR2021-01507, Paper 9 (P.T.A.B. March 9, 2022), the Patent Trial and Appeal Board exercised its discretion under 35 U.S.C. § 325(d) to deny institution of Apotex's petition for inter partes review.

Examiner institution decisionSpring co ltdPlex technologies incAuspex pharms incInstitution decisionApotex incPatent trialAppeal boardElektromedizinische gerAdvanced bionicsReferences wereReferences previously presentedCiting advanced bionicsPatent ownerReferences were cumulativeReference previously

Section 325(d) – Twelfth Time Not A Charm - Intellectual Property

This blog has previously discussed PTAB's exercise of discretion under Section 325(d). Sometimes the PTAB has invoked Section 325(d) to deny institution; sometimes it has declined to apply Section 325(d).

Intel corporationAdvanced bionicsElektromedizinische gerSection 325d x2013 twelfth time nota charmIntellectual property

vimarsana © 2020. All Rights Reserved.